Launch of new RSV vaccine results in encouraging reduction in hospitalisations
A new study from Public Health Scotland, in collaboration with the University of Strathclyde, shows a 62% reduction in respiratory syncytial virus (RSV) related hospitalisations among the eligible age group following introduction of the vaccine.